I
BIO icon

InceptionR’s Bio-Rad Laboratories Class A BIO Stock Holding History

InceptionR’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800K Buy
+2,726
New +$773K 0.2% 192
2025
Q2 		– Sell
-2,127
Closed -$518K – 660
2025
Q1 		$518K Buy
+2,127
New +$640K 0.15% 265
2024
Q4 		– Sell
-800
Closed -$268K – 628
2024
Q3 		$268K Sell
800
-859
-52% -$273K 0.07% 486
2024
Q2 		$453K Buy
+1,659
New +$483K 0.13% 309
2024
Q1 		– Sell
-1,434
Closed -$463K – 587
2023
Q4 		$463K Buy
+1,434
New +$449K 0.33% 122

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

InceptionR's BIO Position: Q2 2026 in Review

InceptionR opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 2,726 shares worth $800K. The stake represents 0.2% of the portfolio and ranks #192 among its holdings. This is a return to the name: InceptionR previously reported a position in BIO as recently as Q1 2025.

InceptionR first reported a position in BIO in Q4 2023 and has held it in 5 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • InceptionR held 2,726 shares of Bio-Rad Laboratories Class A worth $800K as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new InceptionR position in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.2% of InceptionR's portfolio in Q2 2026, its #192 holding.
  • InceptionR first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 5 quarters since.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.